NASA's Technology Transfer Program is seeking companies interested in obtaining license rights to a newly developed technology for creating three-dimensional (3D) tissue-like assemblies (TLAs) of human broncho-epithelial (HBE) cells, aimed at enhancing in vitro research on respiratory virus infections. This innovative technology offers a more accurate representation of the human respiratory environment compared to traditional two-dimensional (2D) cell cultures, facilitating studies on bioactive ingredient tolerance, vaccine impacts, and applications in the cosmetics and textile industries. Interested parties can submit a license application through NASA’s Automated Technology Licensing Application System (ATLAS) and should direct any inquiries to NASA’s Technology Transfer Program at Agency-Patent-Licensing@mail.nasa.gov. Please note that NASA does not provide funding in conjunction with these licenses, and no follow-on procurement is expected from this notice.